Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-15

Clinical Trial Update: Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Entospletinib as monotherapy and in combination with chemotherapy in adults with Acute Myeloid Leukemia; the study is terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entospletinib (entospletinib)

Snippet

Sponsor: Gilead Sciences | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-11-15